Stock COPY COPYTELE INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Copytele Inc OTC Bulletin Board

Equities

COPY

US2177211099

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Copytele Inc
08/05 Anixa Biosciences, Inc. Enters into a Joint Development Agreement with Cleveland Clinic to Develop Novel Vaccines for Various Cancer Types CI
18/04 Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board CI

Chart calendar Copytele Inc

578a28ae4e603.rOdbnUg9k44c85as_aNGI2WuVo_j4jL9hv4wNqLlmRA.24EoqiZxo8RewsP-z_MqSAjxOuStiAeWtpJ7DpCOy3_I1GvXMHjX5kiyxw~0cb2a239fa1cc64674fead167c0aec9e

Upcoming events on Copytele Inc

15/05/2024 EF Hutton Investor Conference

Past events on Copytele Inc

09/05/2024 09:00 pm Sidoti Virtual Micro-Cap Conference
04/04/2024 09:15 pm World Vaccine Congress
21/03/2024 10:30 pm Annual General Meeting
01/03/2024 10:00 pm NeauxCancer Oncology Conference
17/01/2024 10:45 pm Sidoti Micro Cap Investor Conference
10/01/2024 12:30 am Biotech Showcase
10/01/2024 12:30 am JPMorgan Healthcare Conference
07/12/2023 05:00 am Business Update Call
01/11/2023 Ovarian Cancer National Conference
28/09/2023 05:30 pm Cantor Global Healthcare Conference
11/09/2023 H.C. Wainwright Global Investment Conference
29/08/2023 CAR TCR Summit
17/04/2023 11:00 pm American Association for Cancer Research Meeting - Poster Number : 3035 / 7
10/03/2023 Q1 2023 Earnings Release (Projected)
09/03/2023 11:30 pm Annual General Meeting
10/01/2023 05:00 am Biotech Showcase Conference
08/12/2022 04:30 am San Antonio Breast Cancer Symposium - Poster No: OT2-10-02
10/11/2022 07:30 pm Society for Immunotherapy of Cancer Meeting - Abstract #672
28/09/2022 American Association for Cancer Research Biennial Ovarian Cancer Research Symposium
12/09/2022 04:30 pm H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodOctober 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,25
0,25
0%		0,00
0,00
- 		0,51
0,51
-0.1%		0,00
0,00
- 		0,21
0,21
0%
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-5,12
-6,46
20.7%		-5,80
-6,40
9.28%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-11,9
-14,8
19.52%		-9,98
-10,5
4.77%		-13,1
-11,9
-10.77%		-13,9
-13,7
-1.03%		-11,0
-10,8
-1.86%
-14,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-11,8
-14,7
19.61%		-10,1
-10,4
3.29%		-13,1
-11,9
-10.72%		-13,8
-10,4
-32.78%		-9,93
-10,1
1.28%
-14,2

Net income
Million USD		Released
Forecast
Spread 		-11,6
-14,5
19.44%		-10,0
-10,3
2.98%		-13,0
-11,7
-10.33%		-13,6
-10,3
-31.87%		-9,81
-9,97
1.6%
-14,2

EPS
USD		Released
Forecast
Spread 		-0,59
-0,73
19.18%		-0,45
-0,47
4.26%		-0,45
-0,41
-9.76%		-0,45
-0,35
-30.43%		-0,32
-0,32
0%
-0,44

Announcement Date09/01/2007/01/2104/01/2204/01/2316/01/24-

Quarterly results

Fiscal PeriodOctober 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,21
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread


-3,59
-4,10
12.46%		-2,80
-3,90
28.28%		-3,61
-4,10
11.98%


-2,56
-3,50
26.86%		-2,84
-2,80
-1.57%		-3,05
-2,85
-7.05%		-3,61
-2,95
-22.34%
-3,65


-3,65


-3,65







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-3,59
-4,10
12.49%		-2,78
-3,90
28.85%		-3,53
-4,10
13.93%


-2,31
-3,50
34.09%		-2,55
-2,80
9%		-2,72
-2,85
4.53%		-3,29
-2,95
-11.53%
-3,65


-3,65


-3,65







Net income
Million USD		Released
Forecast
Spread


-3,54
-4,10
13.56%		-2,75
-3,90
29.59%		-3,48
-4,10
15.22%


-2,29
-3,50
34.63%		-2,51
-2,80
10.32%		-2,69
-2,85
5.61%		-3,26
-2,95
-10.34%
-3,65


-3,65


-3,65







EPS
USD		Released
Forecast
Spread 		-0,13
-0,13
0%		-0,12
-0,13
7.69%		-0,09
-0,13
30.77%		-0,12
-0,11
-9.09%		-0,08
-0,16
50%		-0,07
-0,12
39.13%		-0,08
-0,09
11.11%		-0,09
-0,09
0%		-0,10
-0,09
-11.11%
-0,11


-0,11


-0,11


-0,11


-0,11

Announcement Date11/03/2210/06/2209/09/2204/01/2317/03/2314/06/2306/09/2316/01/2412/03/24-----

Upcoming sector events for Copytele Inc

13/05/2024 ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 FORTREA HOLDINGS INC.: Q1 2024 Earnings Release
13/05/2024 AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 CENTESSA PHARMACEUTICALS PLC: Q1 2024 Earnings Release (Projected)
13/05/2024 BIOMEA FUSION, INC.: Q1 2024 Earnings Release (Projected)
14/05/2024 BELITE BIO, INC: Q1 2024 Earnings Release
14/05/2024 POLARIS GROUP: Q1 2024 Earnings Release
14/05/2024 ABSCI CORPORATION: Q1 2024 Earnings Release
15/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
16/05/2024 REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected)
More events

Past sector events for Copytele Inc

Today HUMACYTE, INC.: Q1 2024 Earnings Release
Today NOVAVAX, INC.: Q1 2024 Earnings Release
Today TAKARA BIO INC.: Q4 2023 Earnings Release
Today CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected)
10/05/2024 01:35 am BIOHAVEN LTD.: Q1 2024 Earnings Release
10/05/2024 01:35 am OMNIAB, INC.: Q1 2024 Earnings Release
10/05/2024 01:35 am 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release
09/05/2024 05:30 pm CG ONCOLOGY, INC.: Q1 2024 Earnings Release
09/05/2024 05:30 pm DISC MEDICINE, INC.: Q1 2024 Earnings Release
09/05/2024 05:30 pm VERA THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ANIX Stock
  4. COPY Stock
  5. Calendar Copytele Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW